Skip to main content

Table 3 Patient-reported usage of current acute treatment in insufficient responders/sufficient responders to acute treatment for migraine

From: Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme

 

Insufficient responders (N = 227)

Sufficient responders (N = 311)

Total (N = 538)

Time of administration of acute therapy, n (%)*

 At first sign of a migraine

49 (23.0)

94 (31.1)

143 (27.8)

 When/after the pain starts

164 (77.0)

208 (68.9)

372 (72.2)

Continue using currently prescribed acute medication, n (%)*

 Definitely yes

48 (21.6)

132 (43.1)

180 (34.1)

 Probably yes

121 (54.5)

147 (48.0)

268 (50.8)

 Do not know

43 (19.4)

24 (7.8)

67 (12.7)

 Probably not

10 (4.5)

2 (0.7)

12 (2.3)

 Definitely not

0

1 (0.3)

1 (0.2)

Ever needs to take extra doses to relieve pain/migraine symptoms, n (%)*

85 (41.1)

52 (18.7)

137 (28.2)

Number of times extra doses of a prescribed acute medication were taken for the last ten migraine attacks, mean ± SD*a

3.34 ± 2.1

2.14 ± 1.9

2.89 ± 2.1

  1. Reported data are number and percentage of patients, unless stated otherwise, with percentages calculated as proportion of non-missing data
  2. *p < 0.05 between insufficient responders and sufficient responders. For categorical measures, chi-squared or Fisher’s exact test was used. For continuous measures, t-test was used
  3. aAssessed in patients needing to take extra doses to control pain/migraine symptoms
  4. SD standard deviation